What’s Next For OMass After Roche Licensing Deal

 
• By Manas Mishra
  
OMass Therapeutics CEO Rosamond Deegan
OMass Therapeutics CEO Rosamond Deegan (OMass Therapeutics)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from Leadership